ANSYS, Inc. (ANSS) Release: Patient-Specific Simulation to Improve Understanding of Cerebral Aneurysms  
3/2/2009 10:08:20 AM

SOUTHPOINTE, Pa.--(BUSINESS WIRE)--ANSYS, Inc. (NASDAQ: ANSS), a global innovator of simulation software and technologies designed to optimize product development processes, today announced that the @neurIST project has completed a major milestone toward its goal of helping clinicians understand and manage cerebral aneurysms. The project teamed with ANSYS to incorporate high-end engineering simulation, which is being increasingly used in the fields of biomedicine and healthcare.